Omnicell to Report Q2 Earnings: OmniSphere in Focus
OMCL heads into Q2 earnings with OmniSphere adoption, Connected Devices execution and recurring revenue growth ahead of July 30 results.
Zacks Investment Research7/21/2026Neutral
OMCL
Omnicell IncNASDAQHEALTHCAREHEALTH INFORMATION SERVICES
Key Statistics
Market Cap
$1.89B
P/E Ratio
94.30
EPS
$0.44
Beta
0.97
52W High
$55.00
52W Low
$28.90
50-Day MA
$42.44
200-Day MA
$40.18
Dividend Yield
—
Profit Margin
1.67%
Forward P/E
29.50
PEG Ratio
15.40
About Omnicell Inc
Omnicell, Inc., provides medication management automation solutions and adherence tools for health care systems and pharmacies in the United States and internationally. The company is headquartered in Mountain View, California.
Fundamentals
| Revenue (TTM) | $1.23B |
| Gross Profit (TTM) | $537.47M |
| EBITDA | $73.61M |
| Operating Margin | 5.44% |
| Return on Equity | 1.63% |
| Return on Assets | 1.21% |
| Revenue/Share (TTM) | $26.84 |
| Book Value | $27.63 |
| Price-to-Book | 1.49 |
| Price-to-Sales (TTM) | 1.54 |
| EV/Revenue | 1.481 |
| EV/EBITDA | 15.25 |
| Quarterly Earnings Growth (YoY) | -35.90% |
| Quarterly Revenue Growth (YoY) | 14.90% |
| Shares Outstanding | $45.48M |
| Float | $41.95M |
| % Insiders | 2.25% |
| % Institutions | 105.80% |
Historical Volatility
HV 10-Day
53.66%
HV 20-Day
47.20%
HV 30-Day
44.17%
HV 60-Day
40.05%
HV Rank
57.5%
Volatility is currently expanding
Analyst Ratings
Consensus ($61.29 target)
1
Strong Buy6
Buy1
HoldLatest News
Should You Continue to Hold OMCL Stock in Your Portfolio Now?
Omnicell is advancing its autonomous pharmacy vision and expanding SaaS offerings, but tariffs and fierce competition could test its growth path.
Zacks Investment Research7/9/2026Neutral
What's Fueling Omnicell Stock's 52.6% Rally Over the Past Year?
Shares of Omnicell OMCL have rallied 52.6% over the past year, significantly outperforming the industry's 20.8% fall and the S&P 500 composite's 23.9% gain.
Zacks Investment Research7/7/2026Positive
Nnamdi Njoku Appointed President of Omnicell
FORT WORTH, Texas--(BUSINESS WIRE)--Nnamdi Njoku appointed President of Omnicell leading global operations & innovation strategy; Randall Lipps continues as CEO, Chairman of the Board.
Business Wire7/1/2026Neutral
Why Omnicell (OMCL) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research6/30/2026Positive
OMCL or HIMS: Which Is the Better Value Stock Right Now?
Investors interested in Medical Info Systems stocks are likely familiar with Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two companies is the best option for those looking for undervalued stocks?
Zacks Investment Research6/26/2026Positive
Do Options Traders Know Something About Omnicell Stock We Don't?
Investors need to pay close attention to OMCL stock based on the movements in the options market lately.
Zacks Investment Research6/24/2026Neutral
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Investors interested in Medical Info Systems stocks are likely familiar with Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks is more attractive to value investors?
Zacks Investment Research6/10/2026Positive
Omnicell (OMCL) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research6/10/2026Positive
Omnicell, Inc. (OMCL) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Omnicell, Inc. (OMCL) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha6/9/2026Neutral
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on OMCL and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 7/29/2026